Keysight First to Submit Test Cases for Verifying Mobility Enhancements in 5G New Radio Release 16 to 3GPP
Unique Rel-16 test capability speeds market introductions of advanced 5G NR features SANTA ROSA, Calif.–(BUSINESS…
Unique Rel-16 test capability speeds market introductions of advanced 5G NR features SANTA ROSA, Calif.–(BUSINESS…
NEW YORK & HOUSTON–(BUSINESS WIRE)–#proptech–Entera, the leading platform for single-family real estate investors, announced…
NEW YORK–(BUSINESS WIRE)–#brokerdealer–The OTC Markets (OTC) provides a trading platform for the trading of securities…
DANVERS, Mass.–(BUSINESS WIRE)–#BOD—CCC, a leader in advancing copyright, accelerating knowledge, and powering innovation, announces Justin…
Integration Enables Complete, Easy Indirect Tax Compliance and Enhanced Customer Experience AUSTIN, Texas–(BUSINESS WIRE)–Dooap, a…
New AI-based data extraction subscription service successfully launched 18% increase in staffing realigned as a…
SAN FRANCISCO–(BUSINESS WIRE)–Sigma Computing (“Sigma”), the cloud analytics and business intelligence (BI) innovator, today announced…
CAMBRIDGE, Mass.–(BUSINESS WIRE)–#cambridge—Cambridge Savings Bank (CSB), a full-service mutual bank with a customer-first approach and…
PLANO, Texas–(BUSINESS WIRE)–Diodes Incorporated (DIODES™) (Nasdaq: DIOD) has introduced a universal AC high-voltage input non-isolated…
By George Shaw With growing online sales and the climbing number of digital buyers, it…
Banyan Security, Keyfactor, ObserveID, Simeio and strongDM also join alliance to develop identity-centric security strategies…
BOCA RATON, Florida., Feb. 08, 2022 (GLOBE NEWSWIRE) — INmune Bio, Inc. (NASDAQ: INMB) (the “Company”),…
WORCESTER, Mass., Feb. 08, 2022 (GLOBE NEWSWIRE) — Mustang Bio, Inc. (“Mustang”) (NASDAQ: MBIO), a…
SOUTH SAN FRANCISCO, Calif., Feb. 08, 2022 (GLOBE NEWSWIRE) — Satsuma Pharmaceuticals, Inc. (Nasdaq: STSA),…
Joel Prieve brings nearly 20 years of commercial operations expertise and proven track record in…
INT301 Met Safety Goals Across Four Dose Levels in Cohort 1 Patient Treatment Now Ongoing…
Oslo, Norway, 8 February 2022 Vistin Pharma ASA will release its fourth quarter 2021 results…
No additional clinical work required; NDA resubmission anticipated in Q3 2022 NEW YORK, Feb. 08,…
– Ovid to License Gaboxadol to Healx – – Healx to Explore Gaboxadol in Combination…
BELTSVILLE, Md., Feb. 08, 2022 (GLOBE NEWSWIRE) — NextCure, Inc. (Nasdaq: NXTC), a clinical-stage biopharmaceutical…